ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P87-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates- Effective January 6, 2020
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 02, 2019
လံာ်တီလံာ်မီတဖၣ်ဒီး လံာ်ကွီၣ်ဒိတဖၣ်အစၢတဖၣ်
တၢ်ပာ်ဖျါ 2131 - 2140 လၢ 3613 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P86-19 Compliance with SAMSHA Part 2 Regulations and Identifying Claims Subject to Federal Confidentiality of Substance Use Disorder Regulations
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 02, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P88-19 Mental Health Adult and Child Crisis Services Billing
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 02, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
2019 December Bulletins
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 02, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Notice of Medicare Non-Coverage (NOMNC) (PDF)
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP82R1-19 Pharmacy Benefit Update - $0 Insulin Member Cost-Share Benefit for Commercial Lines of Business
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 27, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP95-19 New Drug, Reyvow™ (lasmiditan) Will Require Prior Authorization (PA)
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 27, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP93-19 Provider Cost Data Update
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 27, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 27, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 27, 2019